Menicon creates contact lenses. In response to consumer demand, they increase the range of products and services available. Animal ophthalmic care uses the same technology that was developed for contact lenses for people. They aid in the growth of veterinary ophthalmology in cooperation with veterinarians. Use the technology that has been developed for the creation of care and contact lenses in the environmental business sector.

Tomy Digital Biology Co. Ltd. is a private company headquartered in Japan that distributes surgical and medical instruments.

Saitama Medical University (埼玉医科大学 Saitama Ika Daigaku) is a private university at Moroyama, Saitama, Japan. The predecessor of the school, the Moro Hospital, was founded in 1892, and it was chartered as a university in 1972.

Myriad Genetics, Inc. is an American molecular diagnostic company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new molecular diagnostic products that assess an individual's risk for developing disease later in life (predictive medicine), identify a patient's likelihood of responding to a particular drug therapy (personalized medicine), assess a patient's risk of disease progression and disease recurrence (personalized medicine), and measure disease activity. Myriad's discovery of the breast cancer gene, BRCA1 was universally acclaimed as a monumental achievement: "There is no more exciting story in medical science." Myriad was the subject of scrutiny after it became involved in a lawsuit over its patenting practices, which led to the landmark Supreme Court decision Association for Molecular Pathology v. Myriad Genetics, Inc..

Beijing Kelidandi Biomedical Technology Co., Ltd., established on 2019-07-09, Business scope includes biological,the medical,food,medical artificial intelligence,Technology Development of Electronic Information System,Technology Promotion,Technical Services,technology transfer,technical consulting;Sales of medical devicesIkind,medical instrumentsIIkind,Chemical Products(Free of Hazardous Chemicals),biological reagent(Does not contain drugs);cloud computing center(onlyPUEvalue1.4the following);Agricultural Science Research and Experimental Development;Technology Import and Export,Import and export;Professional contractors;Organize cultural and artistic exchange activities(without show);Solid waste pollution control;retail medicine;wholesale medicine;sell food;wholesale,Retail Class III Medical Devices;Production of the second class,Class III medical devices.(Enterprises independently choose operating projects according to law,Carry out business activities;retail medicine,wholesale medicine,sell food,wholesale,Retail Class III Medical Devices,Production of the second class,Class III medical devices and items subject to approval according to law,Carry out business activities in accordance with the approved content after approval by relevant departments;Do not engage in the business activities of projects prohibited and restricted by the city's industrial policies.).

Guangzhou Myron Information Technology Co., Ltd., established on 2015-12-16, Business scope includes software product development,Production;IC Design;Digital Animation Production;Game software design and production;geographic information processing;Information system integration service;Computer room maintenance service;Information Technology Consulting Services;Data Processing and Storage Services;Sales of products produced by the company(Except for projects prohibited by national laws and regulations;Products involving licensed operation need to obtain a license before they can be operated);Smart Machine System Sales;Smart Machine Sales;Intelligent machine system production;Intelligent Machine System Technical Services;Technical research on police equipment,technology development;

Riken Corp. engages in the manufacture and sale of engine and vehicular components. It operates through the Automotive and Machinery Parts, and Others segments. The Automotive and Machinery Parts segment deals with the company's core products such as piston rings, camshafts, seal rings for transmissions, high-grade cast iron products, and valve lifters. The Others segment includes plumbing equipment business, Electromagnetic Compatibility (EMC) business, and thermal engineering business, The company was founded by Masatoshi Okochi in November 1927 and is headquartered in Tokyo, Japan.

Ustar Biotechnologies (Hangzhou) Ltd. develops and manufactures molecular diagnostic products. Its products include DNA extraction, TB testings, STD testings and DNA detection. The company was founded by Qimin You and Michael Hu in 2005 and is headquartered in Hangzhou, China.

Ningbo Meikang Shengde Medical Laboratory Co., Ltd., established on 2011-12-20, Business scope includes licensed projects:medical service;Internet hospital services relying on physical hospitals;Class III medical device business;Class III Medical Device Leasing(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results).General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Class II Medical Device Leasing;Health Consulting Services(Does not include medical services);Sales of Class I Medical Devices;Sales of Class II Medical Devices;food sales(Only sell prepackaged food);Business Management Consulting(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license).(The branch office is located in:Jinda South Road, Xiaying Street, Yinzhou District, Ningbo City1228No,sand road216No11building)

Jingneng Medical Technology (Shanghai) Co., Ltd., established on 2017-11-23, The scope of business includes engaging in medical technology,Medical Technology,Biological Technology,Information Technology,Technical consulting in the field of health technology,technology development,technology transfer,Technical Services,laboratory equipment,laboratory consumables,Chemical raw materials and products(Removal of hazardous chemicals,Monitor Chemicals,firecrackers,civilian explosives,precursor chemicals),Sales of computer software, hardware and accessories,Medical device management,account Serive,Health Management Consulting(Do not engage in medical activities,psychological counseling),e-commerce(Not allowed to engage in value-added telecommunications,Financial services),Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Jiangsu Bojia Biomedical Technology Co., Ltd., established on 2021-04-02, Business scope includes licensed projects:Production of Class III Medical Devices;Class III medical device business;Veterinary drug production;Quality and safety inspection of agricultural products;Production of Class II Medical Devices;Forestry product quality inspection and testing;Quality inspection of edible fungi;Forest grass seed quality inspection;Crop Seed Quality Inspection;Entry-Exit Quarantine Processing;Import and export commodity inspection and appraisal;Inspection and testing service;Safety production inspection and testing;Indoor environment detection;patent agency;Veterinary drug business;Cosmetic production;Disinfectant production(Free of Hazardous Chemicals);Production of hygiene products and single-use medical products(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Production of Class I Medical Devices;Sales of Class I Medical Devices;Sales of Class II Medical Devices;Water Environment Pollution Prevention and Control Services;Atmospheric Environmental Pollution Prevention and Control Services;Agricultural non-point source and heavy metal pollution prevention and control technical services;Indoor Air Pollution Control;Agricultural Science Research and Experimental Development;Medical Research and Experimental Development;Vector Biodensity Control Level Evaluation Service;Vector Biodensity Monitoring and Evaluation Service;Development of Human Gene Diagnosis and Therapy Technology;R&D of industrial enzyme preparations;Fermentation process optimization technology research and development;Technology intermediary service;New material technology promotion service;New material technology research and development;Vector biological control services;Animal Husbandry Professional and Auxiliary Activities;Sales of air pollution monitoring and testing instruments;Sales of water pollutant monitoring and testing instruments;Manufacturing of ecological environment monitoring and testing instruments;internet sales(Except for products that require a license for sale);Sales of hygiene products and single-use medical products;Specialty Chemicals Sales(Free of Hazardous Chemicals);Experimental analysis instrument sales;Glassware Sales;Retailing of protective equipment for healthcare workers;Cosmetics Wholesale;Disinfectant sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Shanghai Yulong Biotechnology Co., Ltd., established on 2002-05-27, Business scope includes medical devices,In vitro diagnostic reagents(see license)production and marketing,Technology development in the field of biotechnology,technical consulting,Technical Services,technology transfer.[Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

Nanjing Maida Pharmaceutical Technology Co., Ltd., established on 2008-12-30, Business scope includes prodrugs,Intermediate development,Research;preclinical trial,Clinical Trials,Molecular Medicine Research Services;Provide technical advice and services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

First Star (Nanjing) Biotechnology Co., Ltd., established on 2012-04-05, The scope of business includes engaging in testing kits,Research and development of biological products,technical consulting,Technology transfer and service,Scientific reagents,Plastic consumables for scientific research,instrument(Not for clinical use)of domestic procurement,wholesale,commission agent(except auction)and import and export business,and provide related services(Commodities that do not involve state trade management;Quota involved,of license-managed goods,Apply in accordance with relevant national regulations).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

Guangdong Ruihao Biotechnology Co., Ltd., established on 2015-11-10, Business scope includes sports event planning;Wearable smart device sales;Sales of Class II Medical Devices;Sales of hygiene products and single-use medical products;Artificial intelligence theory and algorithm software development;Artificial intelligence innovation and innovation service platform;internet data service;data processing services;food sales(Only sell prepackaged food);Healthy food(prepackaged)Sales;Health Consulting Services(Does not include medical services);Traditional Chinese Medicine Health Care Services(non-medical);Health Care Services(non-medical);Information Consulting Service(Not including licensing information consulting services);Medical Research and Experimental Development;Cosmetics Wholesale;Cosmetics Retail;software development;Remote Health Management Services;Computer System Services;Network technology service;Internet Security Services;internet sales(Except for products that require a license for sale);Information Technology Consulting Services;Artificial intelligence application software development;Development of Human Gene Diagnosis and Therapy Technology;Human stem cell technology development and application;Technology intermediary service;Biomass Energy Technology Services;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;R&D and application of cell technology;Food Internet Sales(Only sell prepackaged food);food business(Only sell prepackaged food);The second type of value-added telecommunications services;Drug internet information service;

Jiangsu Xianstar Biotechnology Co., Ltd., established on 2014-12-10, Business scope includes biotechnology research and development,Medical device research and development,Production,Sales.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments) licensed items:Technology Import and Export;Import and export;Inspection and testing service(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,Specific business projects are subject to approval results) General project:Medical Research and Experimental Development;Technical Services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Specialty Chemicals Sales(Free of Hazardous Chemicals)(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Healx is a mission-driven technology company pioneering the next wave of drug discovery in order to bring novel, effective treatments to rare disease patients around the world. There are 7,000 known rare diseases that affect 400 million people across the globe, but only 5% of those conditions have an approved treatment. By combining frontier AI technology with deep drug discovery and development expertise, Healx can accelerate the pace, increase the scale and improve the chance of success of rare disease treatment development in order to meet this huge unmet need and have unprecedented patient impact. Founded in Cambridge, UK, in 2014 by Dr Tim Guilliams (a Biochemical Engineer and tech entrepreneur) and Dr David Brown (co-inventor of Viagra and former Global Head of Drug Discovery at Roche), Healx has raised $70 million to date. For more information, visit www.healx.io.